T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
First Mid Bancshares
FMBH
$1.39B
| $511K | ﹤0.01% |
13,101
+823
| +7% | +$31.3K |
|
2377
Solid Power
SLDP
$545M
| $509K | ﹤0.01% |
119,730
+39,280
| +49% | +$217K |
|
2378
Janus International
JBI
$686M
| $508K | ﹤0.01% |
77,560
+3,632
| +5% | +$28.3K |
|
2379
N-able
NABL
$695M
| $508K | ﹤0.01% |
67,876
+9,312
| +16% | +$71.1K |
|
2380
Kforce
KFRC
$1.08B
| $507K | ﹤0.01% |
16,382
+1,330
| +9% | +$39.1K |
|
|
HDSN
2381
Hudson Technologies
HDSN
$239M
| $505K | ﹤0.01% |
73,706
| – | – |
|
2382
LSI Industries
LYTS
$912M
| $500K | ﹤0.01% |
27,261
+4,232
| +18% | +$86K |
|
2383
Tejon Ranch
TRC
$443M
| $500K | ﹤0.01% |
31,667
+5,738
| +22% | +$91.5K |
|
2384
Weis Markets
WMK
$1.77B
| $496K | ﹤0.01% |
7,725
-1,272
| -14% | -$84.9K |
|
2385
CorMedix
CRMD
$639M
| $495K | ﹤0.01% |
42,546
+3,271
| +8% | +$36.2K |
|
2386
iHeartMedia
IHRT
$464M
| $495K | ﹤0.01% |
118,957
+7,785
| +7% | +$29.1K |
|
2387
FRP Holdings
FRPH
$425M
| $494K | ﹤0.01% |
21,653
+7,400
| +52% | +$175K |
|
2388
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.1B
| $494K | ﹤0.01% |
5,983
| – | – |
|
2389
Motorcar Parts of America
MPAA
$235M
| $493K | ﹤0.01% |
39,874
| – | – |
|
|
SNBR
2390
DELISTED
Sleep Number
SNBR
| $493K | ﹤0.01% |
58,203
+16,200
| +39% | +$102K |
|
2391
Tronox
TROX
$958M
| $493K | ﹤0.01% |
118,066
+4,876
| +4% | +$18.6K |
|
2392
Vir Biotechnology
VIR
$1.52B
| $493K | ﹤0.01% |
81,611
+34,475
| +73% | +$205K |
|
|
ALMS
2393
Alumis Inc
ALMS
$3.11B
| $493K | ﹤0.01% |
50,422
+22,148
| +78% | +$155K |
|
2394
B&G Foods
BGS
$299M
| $491K | ﹤0.01% |
114,079
+727
| +0.6% | +$3.25K |
|
2395
NWPX Infrastructure Inc
NWPX
$1.11B
| $491K | ﹤0.01% |
7,847
-4,796
| -38% | -$277K |
|
2396
Surrozen
SRZN
$279M
| $491K | ﹤0.01% |
21,715
| – | – |
|
2397
Beazer Homes USA
BZH
$874M
| $489K | ﹤0.01% |
24,120
-4,104
| -15% | -$91.3K |
|
2398
Cullinan Oncology
CGEM
$1.26B
| $489K | ﹤0.01% |
47,187
+3,950
| +9% | +$35.6K |
|
2399
Universal Insurance Holdings
UVE
$1.18B
| $489K | ﹤0.01% |
14,448
+1,089
| +8% | +$34.7K |
|
|
BBUC
2400
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.01B
| $488K | ﹤0.01% |
13,587
+993
| +8% | +$34.8K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.